Skip to content

Effect of target-controlled infusion of different concentrations of remifentanil combined with propofol on PSI and postoperative recovery of patients undergoing gynecological laparoscopic surgery

Effect of target-controlled infusion of different concentrations of remifentanil combined with propofol on PSI and postoperative recovery of patients undergoing gynecological laparoscopic surgery

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040130
Enrollment
Unknown
Registered
2020-11-22
Start date
2020-11-30
Completion date
Unknown
Last updated
2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative recovery

Interventions

group one:change the target concentration of remifentanil
group two:change the target concentration of remifentanil
group three:change the target concentration of remifentanil
group four:change the target concentration of remifentanil

Sponsors

The First Affiliated Hospital of University of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients who intend to undergo laparoscopic gynecological general anesthesia; 2. ASA physical status I– II; 3. 18–65 years of age; 4. BMI from 18.5 kg/m^2 to 29 kg/m^2.

Exclusion criteria

Exclusion criteria: 1. Poor compliance, can not cooperate with the surgery; 2. disease or injury affecting the central nervous system; 3. bradycardia or bypotension; 4. recent use of psychoactive or analgesic medication, neurologic disorders; 5. allergy to iodine, alcohol or drug abuse.

Design outcomes

Primary

MeasureTime frame
Patient state index;Bispectral index;

Secondary

MeasureTime frame
blood presure;heart rate;

Countries

China

Contacts

Public ContactSheng Wang

The First Affiliated Hospital of University of Science and Technology of China

iamsheng2020@ustc.edu.cn+86 19156007726

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026